HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 69 filers reported holding HARVARD BIOSCIENCE INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $796,000 | +12.1% | 260,927 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $710,000 | -4.1% | 260,927 | +0.8% | 0.00% | 0.0% |
| Q2 2016 | $740,000 | -8.2% | 258,869 | -3.1% | 0.00% | 0.0% |
| Q1 2016 | $806,000 | -14.2% | 267,036 | -1.3% | 0.00% | 0.0% |
| Q4 2015 | $939,000 | -9.4% | 270,562 | -1.3% | 0.00% | 0.0% |
| Q3 2015 | $1,036,000 | -35.8% | 274,153 | -3.2% | 0.00% | -50.0% |
| Q2 2015 | $1,614,000 | -2.2% | 283,103 | -0.2% | 0.00% | 0.0% |
| Q1 2015 | $1,651,000 | +1.7% | 283,759 | -0.9% | 0.00% | 0.0% |
| Q4 2014 | $1,624,000 | +77.9% | 286,478 | +28.3% | 0.00% | +100.0% |
| Q3 2014 | $913,000 | -9.7% | 223,321 | +0.6% | 0.00% | 0.0% |
| Q2 2014 | $1,011,000 | -21.1% | 222,099 | -17.8% | 0.00% | 0.0% |
| Q1 2014 | $1,281,000 | +1.3% | 270,229 | +0.4% | 0.00% | 0.0% |
| Q4 2013 | $1,265,000 | -10.2% | 269,176 | +0.5% | 0.00% | 0.0% |
| Q3 2013 | $1,408,000 | +12.3% | 267,738 | +0.4% | 0.00% | 0.0% |
| Q2 2013 | $1,254,000 | – | 266,746 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AMH Equity Ltd | 2,053,907 | $8,626,409 | 9.88% |
| B. Riley Asset Management, LLC | 3,408,796 | $14,316,943 | 5.93% |
| Meros Investment Management, LP | 1,124,206 | $4,721,665 | 2.69% |
| Harvey Partners, LLC | 2,712,700 | $11,393,340 | 1.41% |
| Archon Capital Management LLC | 1,361,769 | $5,719,430 | 1.28% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 2,947,329 | $12,378,782 | 0.80% |
| BARD ASSOCIATES INC | 291,297 | $1,223,448 | 0.50% |
| Portolan Capital Management | 1,043,546 | $4,382,893 | 0.42% |
| HEARTLAND ADVISORS INC | 1,200,000 | $5,040,000 | 0.31% |
| EAM Investors, LLC | 345,546 | $1,451,293 | 0.28% |